Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Immunic, Inc.
Nov 19, 2019
Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips
Nov 07, 2019
Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity
Nov 05, 2019
Immunic, Inc. to Participate in Industry and Investor Conferences in November
Oct 15, 2019
Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson
Oct 10, 2019
Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
Sep 30, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in October
Sep 18, 2019
Immunic, Inc. Doses First Healthy Volunteer in its Phase 1 Clinical Program of IMU-935, a Potentially Best-in-Class RORgt Inverse Agonist
Sep 11, 2019
Immunic, Inc. to Present Selected Available and Previously Unpublished Data Regarding Lead Program, IMU-838, at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis 2019
Sep 05, 2019
Immunic, Inc.'s Interim Dosing Analysis of IMU-838 as Part of its Ongoing Phase 2 CALDOSE-1 Study in Patients with Moderate-to-Severe Ulcerative Colitis Establishes Broad, Potentially Safe and Effective Dose Range
Sep 03, 2019
Immunic, Inc. to Participate in Scientific and Investor Conferences in September
Aug 12, 2019
Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis
Aug 01, 2019
Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project
Jul 30, 2019
Immunic, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference on August 8
Jul 16, 2019
Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer
Jun 21, 2019
Immunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate Update
May 30, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in June
May 09, 2019
Immunic, Inc. to Participate in Upcoming May Conferences
Apr 12, 2019
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases
‹‹
Page 2
Latest News
Apr 18, 2024
Jacam Catalyst to Showcase Pioneering Oilfield Chemical Solutions on “Inside the Blueprint”
Apr 18, 2024
Defense Technology Company, Allen Control Systems, Raises $12 Million Seed Capital to Build Counter-Drone...
Apr 18, 2024
SWTCH Energy Secures $27.2M in Series B Funding to Eliminate EV Charging Gaps in Buildings
Apr 18, 2024
Catalyze Announces Commercial Operation of Renewable Energy Installations for 66 Galen
Apr 18, 2024
Cabot Corporation and Partners Selected for $5M in U.S. Department of Energy Grant to Support Continued...
Apr 18, 2024
General Mills Stands for People and Planet in 2024 Global Responsibility Report
Apr 18, 2024
BZI Named by USA TODAY as a Top Workplace in the Nation
Apr 18, 2024
Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events